Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double‐blind, placebo‐controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Visit 1 or 2 and participated in the following two studies: (1) Finger tapping. Twenty‐five PD patients used their index fingers to strike two keys 20 cm apart on a musical instrument digital interface (MIDI) keyboard. The slopes of the regression line of dwell time and movement time were used to assess the rate of fatigue development. (2) Force generation. Twelve PD patients contracted the wrist extensors maximally to obtain a baseline maximum voluntary contraction (BMVC) force. Then they repetitively contracted the wrist extensors at 50% of the BMVC for 7 seconds and rested for 3 seconds. An interval maximum voluntary contraction (IMVC) was measured every three repetitions. Fatigue was defined as an IMVC of less than 60% of the BMVC. The slope of the regression line of IMVC was used to assess the rate of force decline. These two studies were repeated 1 hour after carbidopa/levodopa (25/100) or placebo. Subjects filled out the Multidimensional Fatigue Inventory (MFI) at the beginning of the first visit. Results showed that the slope of dwell time decreased with levodopa but not with placebo (P = 0.004). The rate of force decline also decreased with levodopa but not with placebo (P = 0.01). The subscores in the dimension of physical fatigue in the MFI did not correlate with the rate changes in dwell time or the rate changes in force decline. We concluded that (1) levodopa improves physical fatigue in finger tapping and force generation, (2) physical fatigue in Parkinson's disease is at least partially related to dopamine deficiency, and (3) the MFI measures different aspects of physical fatigue compared with those measured by finger tapping and force generation. © 2003 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatigue in Parkinson's disease
Friedman, J., & Friedman, H. (1993) · Neurology · doi:10.1212/wnl.43.10.2016 · Cited by 230
Cited by
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
Kluger, B. M., Krupp, L. B., & Enoka, R. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f07be · Cited by 1,036
“Similarly, while some evidence suggests that levodopa therapy may reduce the incidence of fatigue in PD, the effect of levodopa on fatigue remains controversial.(31,32) Table 2 shows the results of selected trials of symptomatic treatments.”
BackgroundInfluentialVigilance, alertness, or sustained attention: physiological basis and measurement
Oken, B. S., Salinsky, M. C., & Elsas, S. M. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.01.017 · Cited by 887
Self-citationCytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Neuropsychiatric symptoms in Parkinson's disease
Aarsland, D., Marsh, L., & Schrag, A. (2009) · Movement Disorders · doi:10.1002/mds.22589 · Cited by 557
Fatigue as a symptom or comorbidity of neurological diseases
Penner, I.-K., & Paul, F. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.117 · Cited by 404
Metadata
- Authors
- Lou, J., Kearns, G., Benice, T., Oken, B., Sexton, G., & Nutt, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 18
- Issue
- 10
- Pages
- 1108-1114
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1973450653
- Cited by
- 133
- References
- 1
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study. https://app.cochat.ai/papers/10.1002/mds.10505
- The paper
- Lou, J., Kearns, G., Benice, T., Oken, B., Sexton, G., & Nutt, J. (2003). Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study. Movement Disorders. https://doi.org/10.1002/mds.10505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.